Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
about
Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates.Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.Inflammatory Markers Related to Microbial Translocation Among HIV-Infected Pregnant Women: A Risk Factor of Preterm Delivery.Timing of Initiation of Antiretroviral Therapy and Risk of Preterm Birth in Studies of HIV-infected Pregnant Women: The Role of Selection Bias.Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.Pregnancy Rates and Outcomes of HIV-Infected Women in Korea
P2860
Q30987069-D924843D-625D-42A2-9C1E-ED6F700496FCQ35551457-4521A961-C0FA-435B-96E4-C0895FFBDDAFQ35859896-8D8EBE1C-2CC8-450B-9F0A-A4A4649BE88AQ35866598-FEEE3095-8C5C-4926-A486-2D7D8785C1A2Q37298218-6DD12277-39B7-49A7-87E2-6B53AD416374Q37342120-28303544-BBBD-4553-9376-D98C3794A3E2Q38551995-B21951DC-4F2F-48F3-ACE9-0D6501550AA3Q39078742-61621CAB-9760-426C-8B9C-15A7EAC132A1Q41057198-5E0B5F05-A991-4A61-897A-127F9DAF460DQ41057213-1D6CED2C-D6B5-4B0C-88C0-51B0BB33222AQ47768538-81F31620-9A60-4477-B62C-BEBC4D3A99B4Q47776480-B11B897F-F3E9-4F5F-B650-BF2B8B89BB7DQ59131834-E31125E2-0FC0-4C86-B692-005934CDF968
P2860
Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Preterm delivery risk in women ...... mother-to-child transmission.
@en
Preterm delivery risk in women ...... mother-to-child transmission.
@nl
type
label
Preterm delivery risk in women ...... mother-to-child transmission.
@en
Preterm delivery risk in women ...... mother-to-child transmission.
@nl
prefLabel
Preterm delivery risk in women ...... mother-to-child transmission.
@en
Preterm delivery risk in women ...... mother-to-child transmission.
@nl
P2093
P2860
P356
P1433
P1476
Preterm delivery risk in women ...... mother-to-child transmission.
@en
P2093
C-E S Short
G P Taylor
P2860
P304
P356
10.1111/HIV.12083
P577
2013-09-11T00:00:00Z